title: [Hemostasis disturbances in premature infants with respiratory distress. Influence of the severity of the distress].
authors.forename: A H
authors.initials: AH
authors.lastname: Jensen
authors.forename: M
authors.initials: M
authors.lastname: Couchard
authors.forename: J P
authors.initials: JP
authors.lastname: Relier
authors.forename: P
authors.initials: P
authors.lastname: Zamet
authors.forename: P
authors.initials: P
authors.lastname: Muller
mesh_terms: D000367:Age Factors; D018450:Disease Progression; D004211:Disseminated Intravascular Coagulation / Q000097:blood* / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D005078:Exchange Transfusion, Whole Blood; D005164:Factor IX / Q000378:metabolism; D005167:Factor VII / Q000378:metabolism; D005169:Factor VIII / Q000378:metabolism; D005170:Factor X / Q000378:metabolism; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000145:classification; D015931:Intensive Care, Neonatal / Q000379:methods; D010958:Plasminogen / Q000378:metabolism; D010976:Platelet Count; D011446:Prospective Studies; D011516:Prothrombin / Q000378:metabolism; D012121:Respiration, Artificial; D012127:Respiratory Distress Syndrome, Newborn / Q000145:classification / Q000150:complications*; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D005338:Fibrin Fibrinogen Degradation Products; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D005340:Fibrinogen; D010958:Plasminogen